Average Co-Inventor Count = 8.54
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (4 from 2,076 patents)
2. Katholieke Universiteit Leuven (2 from 345 patents)
3. Janssen Pharmaceuticals, Inc. (2 from 159 patents)
4. Janssen Sciences Ireland Unlimited Company (2 from 60 patents)
5. Janssen Sciences Ireland Uc (1 from 111 patents)
6. Janssen Biopharma, Inc. (1 from 20 patents)
10 patents:
1. 11795149 - Substituted indoline derivatives as dengue viral replication inhibitors
2. 11407715 - Substituted indoline derivatives as dengue viral replication inhibitors
3. 11339165 - Pyrazolopyrimidines having activity against the respiratory syncytial virus (RSV)
4. 11312727 - Macrocyclic flu endonuclease inhibitors
5. 11117887 - Aryl substituted pyrimidines for use in influenza virus infection
6. 10894793 - Bicyclic pyridine, pyrazine, and pyrimidine derivatives as PI3K beta inhibitors
7. 10611755 - Aryl substituted pyrimidines for use in influenza virus infection
8. 10280170 - Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrazine derivatives and 5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepine derivatives as Ros1 inhibitors
9. 10202387 - Heterocyclyl linked imidazopyridazine derivatives as PI3KB inhibitors
10. 10087187 - Imidazopyridazine derivatives as PI3KB inhibitors